http://www.nbcnews.com/health/cancer/liquid-biopsy-helps-doctors-pick-best-cancer-drug-more-easily-n552606
Posts Categorized: About
When Gene Tests for Breast Cancer Reveal Grim Data but No Guidance
http://www.nytimes.com/2016/03/12/health/breast-cancer-brca-genetic-testing.html
Studies highlight potential for genomic testing in pediatric cancers
http://www.healio.com/hematology-oncology/pediatric-oncology/news/online/%7B4f904174-9f98-43bc-8d27-5ef0de8c7c2c%7D/studies-highlight-potential-for-genomic-testing-in-pediatric-cancers
Genetic Discoveries Prompt Lazarus-Like Recoveries in Cancer Patients
http://www.usnews.com/news/articles/2016-02-24/genetic-discoveries-prompt-lazarus-like-recoveries-in-cancer-patients
Opinion: What A Cancer Cure ‘Moon Shot’ Might Look Like
http://commonhealth.wbur.org/2016/01/opinion-what-a-cancer-cure-moon-shot-might-look-like
Turning your cancer against itself
Turning your cancer against itself
First targeted treatment to improve survival of high-risk patients with acute myeloid leukemia
http://www.news-medical.net/news/20151208/First-targeted-treatment-to-improve-survival-of-high-risk-patients-with-acute-myeloid-leukemia.aspx
A Leap Forward for Precision Cancer Medicine
http://www.usnews.com/news/articles/2015/11/04/wuxi-nextcode-to-sequence-genomes-of-1-000-cancer-patients
The Evolution of Precision Medicine
http://health.usnews.com/health-news/hospital-of-tomorrow/articles/2015/10/20/the-evolution-of-precision-medicine
NIH renews funding for National Center for Image Guided Therapy at Brigham and Women’s Hospital
http://www.brighamandwomens.org/about_bwh/publicaffairs/news/pressreleases/PressRelease.aspx?sub=0&PageID=2149
Brigham and Women’s geneticist receives Lasker award
http://www.brighamandwomens.org/About_BWH/publicaffairs/news/laskeraward.aspx?sub=1
How the way We Fight Cancer Is Changing
http://www.huffingtonpost.ca/dr-james-aw/cancer-drugs-personalized-drugs_b_7646508.html
‘Exceptional responders’ to cancer drugs draw scrutiny from scientists
http://www.washingtonpost.com/national/health-science/looking-for-answers-in-cancers-exceptional-responders/2015/06/13/9cf0ec78-0571-11e5-a428-c984eb077d4e_story.html
New chemical technology boosts potency of targeted cancer therapy
http://www.dana-farber.org/Newsroom/News-Releases/new-chemical-technology-boosts-potency-of-targeted-cancer-therapy.aspx
International study of advanced prostate cancer genome finds abundance of potential targets for drug therapy
http://www.dana-farber.org/Newsroom/News-Releases/international-study-of-advanced-prostate-cancer-genome-finds-abundance-of-potential-targets-for-drug-therapy.aspx
New drug combination extends survival of patients with metastatic colorectal cancer
http://www.dana-farber.org/Newsroom/News-Releases/new-drug-combination-extends-survival-of-patients-with-metastatic-colorectal-cancer.aspx
New targeted drug promising treatment option in resistant EGFR-positive lung cancers
http://www.dana-farber.org/Newsroom/News-Releases/New-targeted-drug-promising-treatment-option-in-resistant-EGFR-positive-lung-cancers.aspx
Webchat: The Latest in Precision Medicine and Lung Cancer
http://www.dana-farber.org/Health-Library/Webchat–The-Latest-in-Precision-Medicine-and-Lung-Cancer.aspx
Minor gene mutations can produce extensive disruption of protein interactions, study finds
http://www.dana-farber.org/Newsroom/News-Releases/minor-gene-mutations-can-produce-extensive-disruption-of-protein-interactions-study-finds.aspx
Olaparib and investigational PI3K inhibitor BKM120 combination active against ovarian and breast cancer subtypes
http://www.dana-farber.org/Newsroom/News-Releases/olaparib-and-investigational-pi3k-inhibitor-bkm120-combination-active-against-ovarian-and-breast-cancer-subtypes.aspx
D’Andrea selected to lead new SU2C Ovarian Cancer Dream Team
http://www.dana-farber.org/Newsroom/News-Releases/dana-farbers-dandrea-selected-to-lead-new-su2c-ovarian-cancer-dream-team.aspx
Unregulated web marketing of genetic tests for personalized cancer care raises concerns in new study
http://www.dana-farber.org/Newsroom/News-Releases/Unregulated-web-marketing-of-genetic-tests-for-personalized-cancer-care-raises-concerns-in-new-study.aspx
Novel precision medicine tool could help personalize cancer treatments
http://www.dana-farber.org/Newsroom/News-Releases/novel-precision-medicine-tool-could-help-personalize-cancer-treatments.aspx
Five things you should know about precision medicine
http://www.dana-farber.org/Newsroom/News-Releases/Dana-Farber-experts-share-five-things-you-should-know-about-precision-medicine.aspx
Study identifies promising drug target in certain breast and ovarian cancers
http://www.dana-farber.org/Newsroom/News-Releases/study-identifies-promising-drug-target-in-certain-breast-and-ovarian-cancers.aspx
Collaborative Effort Helps Develop More Effective Treatment for Brain Tumors
Collaborative Effort Helps Develop More Effective Treatment for Brain Tumors
Large study catalogs genetic culprits in head and neck cancers
http://www.dana-farber.org/Newsroom/News-Releases/large-study-catalogs-genetic-culprits-in-head-and-neck-cancers.aspx
New Immunotherapy Vaccines Show Promise in Treating Brain Tumors
New Immunotherapy Vaccines Show Promise in Treating Brain Tumors
Combined therapy can reduce chance of recurrence in women with small, HER2+ breast tumors, study shows
http://www.dana-farber.org/Newsroom/News-Releases/combined-therapy-can-reduce-chance-of-recurrence-in-women-with-small-her-2-positive-breast-tumors.aspx
Common genetic variations may contribute to treatment-related cognitive problems in children with leukemia
http://www.dana-farber.org/Newsroom/News-Releases/common-genetic-variations-may-contribute-to-treatment-related-cognitive-problems-in-children-with-leukemia.aspx
Disorder in gene-control system is a defining characteristic of cancer, study finds
http://www.dana-farber.org/Newsroom/News-Releases/Disorder-in-gene-control-system-is-a-defining-characteristic-of-cancer-study-finds.aspx
Immunotherapy shows clinical benefit in relapsed transplant recipients
http://www.dana-farber.org/Newsroom/News-Releases/immunotherapy-shows-clinical-benefit-in-relapsed-transplant-recipients.aspx
Stem cell transplant without radiation or chemotherapy pre-treatment shows promise
http://www.dana-farber.org/Newsroom/News-Releases/stem-cell-transplant-without-radiation-or-chemotherapy-pre-treatment-shows-promise.aspx
New test developed at Dana-Farber/Brigham and Women’s Cancer Center speeds treatment decisions for blood cancer patients
http://www.dana-farber.org/Newsroom/News-Releases/new-test-developed-at-dana-farber-brigham-and-womens-cancer-center-speeds-treatment-decisions-for-blood-cancer-patients.aspx
Patient’s dramatic response and resistance to cancer drug traced to unsuspected mutations
http://www.dana-farber.org/Newsroom/News-Releases/patients-dramatic-response-and-resistance-to-cancer-drug-traced-to-unsuspected-mutations.aspx
Unsuspected gene found frequently mutated in colorectal, endometrial cancers
http://www.dana-farber.org/Newsroom/News-Releases/Unsuspected-gene-found-frequently-mutated-in-colorectal-endometrial-cancers.aspx
Researchers identify early sign of pancreatic cancer
http://www.dana-farber.org/Newsroom/News-Releases/Researchers-identify-early-sign-of-pancreatic-cancer.aspx
New view of stomach cancer could hasten better therapies
http://www.dana-farber.org/Newsroom/News-Releases/New-view-of-stomach-cancer-could-hasten-better-therapies.aspx
Study identifies novel genomic changes in the most common type of lung cancer
http://www.dana-farber.org/Newsroom/News-Releases/study-identifies-novel-genomic-changes-in-the-most-common-type-of-lung-cancer.aspx
Scientists Engineer Nanoparticles to Prevent Bone Cancer, Strengthen Bones
http://brighamandwomens.org/about_bwh/publicaffairs/news/pressreleases/PressRelease.aspx?sub=0&PageID=1817
Genomic Technology Enters the Mainstream Practice of Medicine
http://brighamandwomens.org/about_bwh/publicaffairs/news/pressreleases/PressRelease.aspx?sub=0&PageID=1815
Many patients with rare gastrointestinal tumor receive long-term benefit from targeted therapy, researchers report
http://www.dana-farber.org/Newsroom/News-Releases/many-patients-with-rare-gastrointestinal-tumor-receive-long-term-benefit-from-targeted-therapy-researchers-report.aspx
Drug-resistant lung tumors respond to new precision therapy in early-stage trial
http://www.dana-farber.org/Newsroom/News-Releases/Drug-resistant-lung-tumors-respond-to-new-precision-therapy-in-early-stage-trial.aspx
Precision medicine for lung cancer marks tenth anniversary
http://www.dana-farber.org/Newsroom/News-Releases/precision-medicine-for-lung-cancer-marks-tenth-anniversary.aspx
FDA approves first targeted drug for advanced stomach cancer
http://www.dana-farber.org/Newsroom/News-Releases/fda-approves-first-targeted-drug-for-advanced-stomach-cancer.aspx
Genomic testing links ‘exceptional’ drug response to rare mutations in bladder cancer
http://www.dana-farber.org/Genomic-testing-links-exceptional-drug-response-to-rare-mutations-bladder-cancer.aspx
Study reports success in targeted therapy for common form of lung cancer
http://www.dana-farber.org/Newsroom/News-Releases/Study-reports-success-in-targeted-therapy-for-common-form-of-lung-cancer.aspx
Targeted therapy boosts lung cancer outcomes
http://www.dana-farber.org/NewsRoom/News-Releases/targeted-therapy-boosts-lung-cancer-outcomes.aspx
Some patients with incurable tumors and BRCA mutations respond to new two-drug combination
http://www.dana-farber.org/Newsroom/News-Releases/some-patients-with-incurable-tumors-and-brca-mutations-respond-to-new-two-drug-combination.aspx
Genomic sequencing identifies mutant ‘drivers’ of common brain tumor
http://www.dana-farber.org/Newsroom/News-Releases/Genomic-sequencing-identifies-mutant-drivers-of-common-brain-tumor.aspx
